Background Optimal antihypertensive medication for chronic Type B aortic dissection
remains undecided. This study compared the efficacy and safety of sacubitril/valsartan with …

Aortic dissection (AD) impacts around 4.8 per 100,000 individuals per year1. Intimal tears in
the descending aorta, Stanford type B aortic dissections (TBAD), account for 25–40% of …

Aortic dissection is a life‐threatening condition. However, the use of medication to treat it
remains unclear in our population, particularly in patients with a type B aortic dissection …

Background Thoracic aortic dissection (TAD) is a severe and often lethal complication in
people with hypertension. Current practice in the treatment of chronic type B aortic …

Strict blood pressure control is pivotal in the management of patients with aortic dissection
(AD), but is frequently difficult to achieve. We determined antihypertensive medical therapy …

Ambulatory blood pressure (BP) measurement (ABPM) is recommended to assess optimal
BP control, and we studied its influence after an acute type B aortic dissection (ATBAD). We …

Background: Aim of this study was to compare the modifications of systemic blood pressure
in patients with subacute type b aortic dissection (TBAD) and refractory (rHTN) and non …

Background Medical therapy gives excellent short-term outcomes for patients with Stanford
type B acute aortic dissection. However, the affected aorta is often compromised by …

Importance The associations between long-term treatment of aortic dissection with various
medications and late patient outcomes are poorly understood. Objective To compare late …

Background: Surgical patients with aortic dissection often require multiple antihypertensive
drugs to control blood pressure. However, the prescription pattern and effectiveness of …